Gordon Findlay, a Novo Nordisk executive, unexpectedly collapsed while standing behind President Donald Trump during a White House press conference. The event was held to announce a new agreement on weight-loss medications.
Findlay's knees suddenly gave out, causing him to buckle. Administration officials and pharmaceutical representatives quickly intervened to prevent him from falling to the floor.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
— White House Press Secretary Karoline Leavitt
Witnesses reported that Dr. Mehmet Oz, the Administrator for Centers for Medicare & Medicaid Services, helped Findlay safely to the ground, avoiding head injury. Reporters were then asked to leave the Oval Office while cabinet members assisted Findlay and elevated his legs.
According to Leavitt, the conference was set to continue shortly after the incident.
During a White House announcement on weight-loss medication, a Novo Nordisk executive fainted but received immediate medical assistance and recovered quickly, allowing the event to resume.